Zafgen Cuts Deal With Argenta

Xconomy Boston — 

Zafgen, the Cambridge, MA-based developer of drugs to shrink fat tissue, said today it has formed a partnership with Harlow, UK-based Argenta Discovery. Argenta, a contract research firm, will assist with the development of one of Zafgen’s experimental treatments for obesity. Earlier this week, we profiled this company’s quest to pioneer a new method of treatment which cuts off blood flow to fat tissue. Financial terms of the new partnership weren’t disclosed.